Bristol Myers Squibb Stock Performance
| BMYMP Stock | USD 1,003 2.93 0.29% |
On a scale of 0 to 100, Bristol-Myers Squibb holds a performance score of 14. The firm shows a Beta (market volatility) of 0.0817, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Bristol-Myers Squibb's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bristol-Myers Squibb is expected to be smaller as well. Please check Bristol-Myers Squibb's potential upside, and the relationship between the total risk alpha and kurtosis , to make a quick decision on whether Bristol-Myers Squibb's price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak primary indicators, Bristol-Myers Squibb reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 15 B | |
| Total Cashflows From Investing Activities | -538 M |
Bristol-Myers |
Bristol-Myers Squibb Relative Risk vs. Return Landscape
If you would invest 80,000 in Bristol Myers Squibb on November 17, 2025 and sell it today you would earn a total of 20,293 from holding Bristol Myers Squibb or generate 25.37% return on investment over 90 days. Bristol Myers Squibb is currently producing 0.3745% returns and takes up 2.0475% volatility of returns over 90 trading days. Put another way, 18% of traded pink sheets are less volatile than Bristol-Myers, and 93% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Bristol-Myers Squibb Target Price Odds to finish over Current Price
The tendency of Bristol-Myers Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1,003 | 90 days | 1,003 | roughly 2.36 |
Based on a normal probability distribution, the odds of Bristol-Myers Squibb to move above the current price in 90 days from now is roughly 2.36 (This Bristol Myers Squibb probability density function shows the probability of Bristol-Myers Pink Sheet to fall within a particular range of prices over 90 days) .
Bristol-Myers Squibb Price Density |
| Price |
Predictive Modules for Bristol-Myers Squibb
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bristol Myers Squibb. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Bristol-Myers Squibb Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bristol-Myers Squibb is not an exception. The market had few large corrections towards the Bristol-Myers Squibb's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bristol Myers Squibb, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bristol-Myers Squibb within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.30 | |
β | Beta against Dow Jones | 0.08 | |
σ | Overall volatility | 54.16 | |
Ir | Information ratio | 0.11 |
Bristol-Myers Squibb Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bristol-Myers Pink Sheet often depends not only on the future outlook of the current and potential Bristol-Myers Squibb's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bristol-Myers Squibb's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.6 B | |
| Cash And Short Term Investments | 17.2 B |
Bristol-Myers Squibb Fundamentals Growth
Bristol-Myers Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Bristol-Myers Squibb, and Bristol-Myers Squibb fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bristol-Myers Pink Sheet performance.
| Revenue | 46.38 B | |||
| EBITDA | 20.1 B | |||
| Cash And Equivalents | 6.07 B | |||
| Cash Per Share | 3.72 X | |||
| Total Debt | 39.6 B | |||
| Debt To Equity | 59.40 % | |||
| Book Value Per Share | 7.55 X | |||
| Cash Flow From Operations | 16.21 B | |||
| Total Asset | 109.31 B | |||
About Bristol-Myers Squibb Performance
Assessing Bristol-Myers Squibb's fundamental ratios provides investors with valuable insights into Bristol-Myers Squibb's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Bristol-Myers Squibb is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol Myers operates under Drug Manufacturers - Major classification in USA and is traded on OTC Market. It employs 23700 people.Things to note about Bristol Myers Squibb performance evaluation
Checking the ongoing alerts about Bristol-Myers Squibb for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Bristol Myers Squibb help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Bristol-Myers Squibb's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Bristol-Myers Squibb's pink sheet performance include:- Analyzing Bristol-Myers Squibb's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bristol-Myers Squibb's stock is overvalued or undervalued compared to its peers.
- Examining Bristol-Myers Squibb's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bristol-Myers Squibb's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bristol-Myers Squibb's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bristol-Myers Squibb's pink sheet. These opinions can provide insight into Bristol-Myers Squibb's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Bristol-Myers Pink Sheet Analysis
When running Bristol-Myers Squibb's price analysis, check to measure Bristol-Myers Squibb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol-Myers Squibb is operating at the current time. Most of Bristol-Myers Squibb's value examination focuses on studying past and present price action to predict the probability of Bristol-Myers Squibb's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol-Myers Squibb's price. Additionally, you may evaluate how the addition of Bristol-Myers Squibb to your portfolios can decrease your overall portfolio volatility.